Arpita Kulshrestha Selected Research

Proton Pumps (Proton Pump)

10/2020	In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.
9/2017	Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
10/2015	Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression.
2/2015	Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arpita Kulshrestha Research Topics

Disease

14	Neoplasms (Cancer) 10/2020 - 02/2015
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 02/2015
5	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2015
4	Visceral Leishmaniasis (Kala Azar) 12/2018 - 01/2012
2	Inflammation (Inflammations) 01/2016 - 10/2015
2	Carcinoma (Carcinomatosis) 01/2016 - 02/2015
2	Premature Obstetric Labor (Premature Labor) 01/2016 - 10/2015
2	Leishmaniasis 02/2013 - 01/2012
1	Carcinogenesis 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Shock 07/2012
1	Infections 03/2012

Drug/Important Bio-Agent (IBA)

10	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 02/2015
8	Protein Isoforms (Isoforms)IBA 10/2020 - 02/2015
6	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 09/2018 - 02/2015
4	Proton Pumps (Proton Pump)IBA 10/2020 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2012
4	Pharmaceutical PreparationsIBA 12/2018 - 01/2012
3	miltefosine (Impavido)IBA 12/2018 - 01/2012
3	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 12/2018 - 01/2012
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2016
2	PlatinumIBA 01/2019 - 01/2016
2	LigandsIBA 01/2016 - 10/2015
2	delta proteinIBA 01/2016 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2015
2	Notch ReceptorsIBA 01/2016 - 10/2015
2	Jagged-1 ProteinIBA 01/2016 - 10/2015
1	Protons (Proton)IBA 10/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	InterleukinsIBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	BenzopyransIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 11/2016
1	Mifepristone (RU 486)FDA Link 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2015
1	Cytidine Monophosphate (CMP)IBA 10/2015
1	Peptidoglycan (Murein)IBA 10/2015
1	Poly I-CIBA 10/2015
1	Actins (F Actin)IBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	CortactinIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015
1	Histones (Histone)IBA 07/2012
1	Glutamate-Cysteine LigaseIBA 07/2012
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 07/2012
1	ProteomeIBA 07/2012
1	AntimonyIBA 07/2012
1	Staphylococcal Protein A (Protein A)IBA 07/2012
1	AntigensIBA 03/2012

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2012
1	Treatment Delay 10/2020
1	Immunotherapy 10/2020
1	Subcutaneous Injections 01/2016